Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients wit...
Leadership
Michael G. Raab
President, CEO & Director
Sue Hohenleitner
Chief Financial Officer
John Bishop Ph.D.
Chief Technical & Quality Officer
Joseph Reilly
Senior VP of Finance & Principal Accounting Officer
Caitlin Lowie
Vice President of Corporate Communications & Investor Relations
Felecia W. Ettenberg
Chief Legal Officer
James P. Brady
Chief Human Resources Officer
Laura A. Williams M.D., M.P.H.
Chief Patient Officer & Interim Chief Medical Officer
